Associations differ by sex for catechol-O-methyltransferase genotypes and bladder cancer risk in South Egypt

Urologic Oncology: Seminars and Original Investigations

Volumn 30, Issue 6, 2012, Pages 841-847

  Wolpert, Beverly J ^a   Amr, Sania ^a   Saleh, Doa'a A ^b   Ezzat, Sameera ^c   Gouda, Iman ^d   Loay, Iman ^d   Hifnawy, Tamer ^e   Abdel Hamid, Mohamed ^f   Mikhail, Nabiel N ^g   Zhan, Min ^a   Zheng, Yun Ling ^h   Squibb, Katherine ^a   Abdel Aziz, Mohamed A ⁱ   Zaghloul, Mohamed S ^d   Khaled, Hussein ^d   Loffredo, Christopher A ^h  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b CAIRO UNIVERSITY   (Egypt)

^c MENOUFIA UNIVERSITY   (Egypt)

^d NATIONAL CANCER INSTITUTE   (Egypt)

^e BENI SUEF UNIVERSITY   (Egypt)

^f MINIA UNIVERSITY   (Egypt)

^g ASSIUT UNIVERSITY   (Egypt)

^h GEORGETOWN UNIVERSITY   (United States)

ⁱ Assiut University Faculty of Medicine   (Egypt)

Author keywords

Catechol O methyltransferase gene polymorphism; Egypt; Schistosomiasis; Sex differences; Smoking; Urinary bladdercancer

Indexed keywords

CATECHOL METHYLTRANSFERASE;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER RISK; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; EGYPT; ENZYME ACTIVITY; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTMENOPAUSE; PRIORITY JOURNAL; QUESTIONNAIRE; REAL TIME POLYMERASE CHAIN REACTION; RISK; RISK FACTOR; SCHISTOSOMIASIS; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE; TRANSITIONAL CELL CARCINOMA;

ADULT; AGED; CARCINOMA; CASE-CONTROL STUDIES; CATECHOL O-METHYLTRANSFERASE; EGYPT; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; REAL-TIME POLYMERASE CHAIN REACTION; RISK FACTORS; SEX FACTORS; URINARY BLADDER NEOPLASMS;

EID: 84870511189     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2010.09.007     Document Type: Article

References (38)

1. Felix A.S., Soliman A.S., Khaled H., et al. The changing patterns of bladder cancer in Egypt over the past 26 years. Cancer Causes Control 2008, 19:421-429.
2. Ibrahim A.S., Khaled H.M. Urinary bladder cancer (Chapter 11). Cancer incidence in four member countries (Cyprus, Egypt, Israel, and Jordan) of the Middle East Cancer Consortium (MECC) compared with US. SEER [NIH Pub. No. 06-5873] 2006, National Cancer Institute, Bethesda, MD. L.S. Freedman, B.K. Edwards, L.A.G. Ries (Eds.).
3. Scelo G., Brennan P. The epidemiology of bladder and kidney cancer. Nat Clin Pract Urol 2007, 4:205-217.
4. Hartge P., Harvey E.B., Linehan W.M., et al. Unexplained excess risk of bladder cancer in men. J Natl Cancer Inst 1990, 82:1636-1640.
5. Hemelt M., Yamamoto H., Cheng K.K., et al. The effect of smoking on the male excess of bladder cancer: A meta-analysis and geographical analyses. Int J Cancer 2009, 124:412-419.
6. Parkin D.M., Bray F., Ferlay J., et al. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55:74-108.
7. Tworoger S.S., Chubak J., Aiello E.J., et al. Association of CYP17, CYP19, CYP1B1, and COMT polymorphisms with serum and urinary sex hormone concentrations in postmenopausal women. Cancer Epidemiol Biomarkers Prev 2004, 13:94-101.
8. Sanderson T., van den Berg M. Interactions of xenobiotics with the steroid hormone biosynthesis pathway. Pure Appl Chem 2003, 75:1957-1971.
9. Yager J.D. Endogenous estrogens as carcinogens through metabolic activation. J Natl Cancer Inst Monogr 2000, 2000:67-73.
10. Yager J.D., Liehr J.G. Molecular mechanisms of estrogen carcinogenesis. Annu Rev Pharmacol Toxicol 1996, 36:203-232.
11. Liehr J.G., Avitts T.A., Randerath E., et al. Estrogen-induced endogenous DNA adduction: Possible mechanism of hormonal cancer. Proc Natl Acad Sci U S A 1986, 83:5301-5305.
12. Schneider J., Huh M.M., Bradlow H.L., et al. Antiestrogen action of 2-hydroxyestrone on MCF-7 human breast cancer cells. J Biol Chem 1984, 259:4840-4845.
13. Nutter L.M., Ngo E.O., Abul-Hajj Y.J. Characterization of DNA damage induced by 3,4-estrone-o-quinone in human cells. J Biol Chem 1991, 266:16380-16386.
14. LaVallee T.M., Zhan X.H., Herbstritt C.J., et al. 2-Methoxyestradiol inhibits proliferation and induces apoptosis independently of estrogen receptors alpha and beta. Cancer Res 2002, 62:3691-3697.
15. Axelrod J., Tomchick R. Enzymatic O-methylation of epinephrine and other catechols. J Biol Chem 1958, 233:702-705.
16. Dawling S., Roodi N., Mernaugh R.L., et al. Catechol-O-methyltransferase (COMT)-mediated metabolism of catechol estrogens: Comparison of wild-type and variant COMT isoforms. Cancer Res 2001, 61:6716-6722.
17. Zhu B.T. Catechol-O-methyltransferase (COMT)-mediated methylation metabolism of endogenous bioactive catechols and modulation by endobiotics and xenobiotics: Importance in pathophysiology and pathogenesis. Curr Drug Metab 2002, 3:321-349.
18. Fontana L., Delort L., Joumard L., et al. Genetic polymorphisms in CYP1A1, CYP1B1, COMT, GSTP1, and NAT2 genes and association with bladder cancer risk in a French cohort. Anticancer Res 2009, 29:1631-1635.
19. Hung R.J., Boffetta P., Brennan P., et al. Genetic polymorphisms of MPO, COMT, MnSOD, NQO1, interactions with environmental exposures and bladder cancer risk. Carcinogenesis 2004, 25:973-978.
20. Manuguerra M., Matullo G., Veglia F., et al. Multifactor dimensionality reduction applied to a large prospective investigation on gene-gene and gene-environment interactions. Carcinogenesis 2007, 28:414-422.
21. Wolpert B.J., Amr S., Ezzat S., et al. Estrogen exposure and bladder cancer risk in Egyptian women. Maturitas 2010, in press/available online before print at. http://www.maturitas.org/inpress, 10.1016/j.maturitas. 2010.07.014.
22. Dawling S., Roodi N., Parl F.F. Methoxyestrogens exert feedback inhibition on cytochrome P450 1A1 and 1B1. Cancer Res 2003, 63:3127-3132.
23. Lotta T., Vidgren J., Tilgmann C., et al. Kinetics of human soluble and membrane-bound catechol-O-methyltransferase: A revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 1995, 34:4202-4210.
24. Zhu B.T., Conney A.H. Functional role of estrogen metabolism in target cells: Review and perspectives. Carcinogenesis 1998, 19:1-27.
25. Eriksson A.L., Skrtic S., Niklason A., et al. Association between the low activity genotype of catechol-O-methyltransferase and myocardial infarction in a hypertensive population. Eur Heart J 2004, 25:386-391.
26. Cantor K.P., Lynch C.F., Johnson D. Bladder cancer, parity, and age at first birth. Cancer Causes Control 1992, 3:57-62.
27. Nathan L., Chaudhuri G. Antioxidant and pro-oxidant actions of estrogens: Potential physiological and clinical implications. Semin Reprod Endocrinol 1998, 16:309-314.
28. Baron J.A. Smoking and estrogen-related disease. Am J Epidemiol 1984, 119:9-22.
29. Zhu B.T., Ezell E.L., Liehr J.G. Catechol-O-methyltransferase-catalyzed rapid O-methylation of mutagenic flavonoidsMetabolic inactivation as a possible reason for their lack of carcinogenicity in vivo. J Biol Chem 1994, 269:292-299.
30. Wiencke J.K., Pemble S., Ketterer B., et al. Gene deletion of glutathione S-transferase θ: Correlation with induced genetic damage and potential role in endogenous mutagenesis. Cancer Epidemiol Biomarkers Prev 1995, 4:253-259.
31. Kelsey K.T., Spitz M.R., Zuo Z.F., et al. Polymorphisms in the glutathione S-transferase class μ and θ genes interact and increase susceptibility to lung cancer in minority populations (Texas, United States). Cancer Causes Control 1997, 8:554-559.
32. Lundstrom K., Tenhunen J., Tilgmann C., et al. Cloning, expression and structure of catechol-O-methyltransferase. Biochim Biophys Acta 1995, 1251:1-10.
33. Worda C., Sator M.O., Schneeberger C., et al. Influence of the catechol-O-methyltransferase (COMT) codon 158 polymorphism on estrogen levels in women. Hum Reprod 2003, 18:262-266.
34. Murta-Nascimento C., Schmitz-Dräger B.J., Zeegers M.P., et al. Epidemiology of urinary bladder cancer: From tumor development to patient's death. World J Urol 2007, 25:285-295.
35. Engel L.S., Taioli E., Pfeiffer R., et al. Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: A Huge review. Am J Epidemiol 2002, 156:95-109. [and Erratum in: Am J Epidemiol 2002;156:492].
36. Marcus P.M., Vineis P., Rothman N. NAT2 slow acetylation and bladder cancer risk: A meta-analysis of 22 case-control studies conducted in the general population. Pharmacogenetics 2000, 10:115-122.
37. Coles B., Ketterer B. The role of glutathione and glutathione transferases in chemical carcinogenesis. Crit Rev Biochem Mol Biol 1990, 25:47-70.
38. Botelho M.C., Crespo M., Almeida A., et al. Schistosoma haematobium and Schistosomiasis mansoni: Production of an estradiol-related compound detected by ELISA. Exp Parasitol 2009, 122:250-253.